Sign Out
Limited data are available on the use of Phospholipids (Essentiale Max) 600 mg hard capsules in pregnant women. Animal studies concerning reproduction toxicity are insufficient (see Pharmacology: Toxicology: Preclinical safety data under Actions).
Use of Phospholipids (Essentiale Max) 600 mg hard capsules in pregnant women is not recommended.
It is not known whether components of soybean phospholipids or their metabolites pass into breast milk. A risk for breast-fed infants cannot be ruled out. Phospholipids (Essentiale Max) 600 mg hard capsules should not be taken by breast-feeding women.
Preclinical studies in animals have not demonstrated an effect on male or female fertility.
